How Afton Scientific’s Quality-First Approach Fuels Its $200 Million Expansion

“Trust is what your customers need most. They take a great risk when they sign up with you to make their product. They need access within your organization to feel confident you’ll get things done the way they want.”

Thomas Thorpe, CEO of Afton Scientific, brings 45 years of pharmaceutical operations experience to his founder-led Contract Development and Manufacturing Organisation (CDMO), which has grown from bootstrapped beginnings to a company with close to 100 employees specialising in sterile injectable manufacturing.

In the latest PharmaSource podcast episode, Tom explains how his experience working for large pharmaceutical companies shaped his approach to building a CDMO that prioritises customer relationships, regulatory compliance, and strategic growth investments—now culminating in a $200 million expansion plan.

Read the full article